Evidence map›Paper›PMID 34400515›Full record

ArticleJournal of epidemiology and community health2022

Variation in colon cancer survival for patients living and receiving care in London, 2006-2013: does where you live matter?

Manuela Quaresma, James R Carpenter, Adrian Turculet, Bernard Rachet

Open access · hybridAbstract read
In one paragraph

Article in Journal of epidemiology and community health, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.2field-weighted citation impact, top 46% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 3 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Manuela QuaresmaNon-Communicable Disease Epidemiology, London School of Hygiene & Tropical Medicine, London, UK manuela.quaresma@lshtm.ac.uk.ORCID 0000-0002-5290-279X
James R CarpenterMedical Statistics, London School of Hygiene & Tropical Medicine, London, UK.
Adrian TurculetNon-Communicable Disease Epidemiology, London School of Hygiene & Tropical Medicine, London, UK.
Bernard RachetNon-Communicable Disease Epidemiology, London School of Hygiene & Tropical Medicine, London, UK.
London School of Hygiene & Tropical Medicine · GB

Funding

Cancer Research UK 18525Cancer Research UK 29018
6 · The paper itself

Abstract

backgroundMarked geographical disparities in survival from colon cancer have been consistently described in England. Similar patterns have been observed within London, almost mimicking a microcosm of the country's survival patterns. This evidence has suggested that the area of residence plays an important role in the survival from cancer.

methodsWe analysed the survival from colon cancer of patients diagnosed in 2006-2013, in a pre-pandemic period, living in London at their diagnosis and received care in a London hospital. We examined the patterns of patient pathways between the area of residence and the hospital of care using flow maps, and we investigated whether geographical variations in survival from colon cancer are associated with the hospital of care. To estimate survival, we applied a Bayesian excess hazard model which accounts for the hierarchical structure of the data.

resultsGeographical disparities in colon cancer survival disappeared once controlled for hospitals, and the disparities seemed to be augmented between hospitals. However, close examination of patient pathways revealed that the poorer survival observed in some hospitals was mostly associated with higher proportions of emergency diagnosis, while their performance was generally as expected for patients diagnosed through non-emergency routes. DISCUSSION: This study highlights the need to better coordinate primary and secondary care sectors in some areas of London to improve timely access to specialised clinicians and diagnostic tests. This challenge remains crucially relevant after the recent successive regroupings of Clinical Commissioning Groups (which grouped struggling areas together) and the observed exacerbation of disparities during the COVID-19 pandemic.

Indexed as

Colonic NeoplasmsCOVID-19Bayes TheoremHumansLondonPandemicsSARS-CoV-2Survival Analysisgeographyhealth policyinequalitiesmultilevel modellingneoplasms

Identifiers

PMID34400515
PMCPMC8762004
OpenAlexW3194496339

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.